OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 87 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $163,755 | -59.1% | 14,466 | -49.3% | 0.00% | – |
| Q4 2023 | $400,472 | -81.1% | 28,544 | -83.3% | 0.00% | -100.0% |
| Q3 2023 | $2,115,913 | +234.4% | 171,329 | -6.0% | 0.01% | -44.4% |
| Q1 2023 | $632,709 | +725.1% | 182,337 | +482.5% | 0.01% | +800.0% |
| Q4 2022 | $76,687 | -74.8% | 31,301 | -56.2% | 0.00% | -87.5% |
| Q1 2022 | $304,000 | -83.0% | 71,414 | -62.5% | 0.01% | -85.5% |
| Q4 2021 | $1,783,000 | – | 190,523 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |